IE63496B1 - The use of pSG5 as a temperature-sensitive plasmid - Google Patents
The use of pSG5 as a temperature-sensitive plasmidInfo
- Publication number
- IE63496B1 IE63496B1 IE89889A IE89889A IE63496B1 IE 63496 B1 IE63496 B1 IE 63496B1 IE 89889 A IE89889 A IE 89889A IE 89889 A IE89889 A IE 89889A IE 63496 B1 IE63496 B1 IE 63496B1
- Authority
- IE
- Ireland
- Prior art keywords
- marker
- plasmid
- psg5
- streptomycetes
- temperature
- Prior art date
Links
- 239000013612 plasmid Substances 0.000 title claims abstract description 39
- 241001655322 Streptomycetales Species 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- 239000003550 marker Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- 238000002955 isolation Methods 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 2
- 238000005215 recombination Methods 0.000 claims 1
- 230000006798 recombination Effects 0.000 claims 1
- 238000012216 screening Methods 0.000 abstract description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- NSFFHOGKXHRQEW-UHFFFAOYSA-N Thiostrepton B Natural products N1C(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC(C(C2=N3)O)C=CC2=C(C(C)O)C=C3C(=O)OC(C)C(C=2SC=C(N=2)C2N=3)NC(=O)C(N=4)=CSC=4C(C(C)(O)C(C)O)NC(=O)C(N=4)CSC=4C(=CC)NC(=O)C(C(C)O)NC(=O)C(N=4)=CSC=4C21CCC=3C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-UHFFFAOYSA-N 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 229930188070 thiostrepton Natural products 0.000 description 4
- 229940063214 thiostrepton Drugs 0.000 description 4
- NSFFHOGKXHRQEW-AIHSUZKVSA-N thiostrepton Chemical compound C([C@]12C=3SC=C(N=3)C(=O)N[C@H](C(=O)NC(/C=3SC[C@@H](N=3)C(=O)N[C@H](C=3SC=C(N=3)C(=O)N[C@H](C=3SC=C(N=3)[C@H]1N=1)[C@@H](C)OC(=O)C3=CC(=C4C=C[C@H]([C@@H](C4=N3)O)N[C@H](C(N[C@@H](C)C(=O)NC(=C)C(=O)N[C@@H](C)C(=O)N2)=O)[C@@H](C)CC)[C@H](C)O)[C@](C)(O)[C@@H](C)O)=C\C)[C@@H](C)O)CC=1C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-AIHSUZKVSA-N 0.000 description 4
- NSFFHOGKXHRQEW-OFMUQYBVSA-N thiostrepton A Natural products CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]4NC(=O)c5csc(n5)[C@@H](NC(=O)[C@H]6CSC(=N6)C(=CC)NC(=O)[C@@H](NC(=O)c7csc(n7)[C@]8(CCC(=N[C@@H]8c9csc4n9)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)[C@](C)(O)[C@@H](C)O)[C@H](C)O NSFFHOGKXHRQEW-OFMUQYBVSA-N 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 102000006382 Ribonucleases Human genes 0.000 description 3
- 108010083644 Ribonucleases Proteins 0.000 description 3
- 241000948169 Streptomyces viridosporus Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000187398 Streptomyces lividans Species 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000531819 Streptomyces venezuelae Species 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000007169 ligase reaction Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The streptomycetes plasmid pSG5 is temperature-sensitive. It is thus possible with the aid of the pSG5 replicon to prepare temperature-sensitive hybrid plasmids. The latter are suitable for screening for DNA segments which are homologous with DNA segments of the hybrid plasmid.
Description
European Patent (EP-B) No. 0,158,872 discloses the Streptomycetes plasmid pSG5 which can be isolated from a culture of Streptomyces ghanaensis DSM 2932. This plasmid is suitable for the preparation of hybrid vectors, for example for what are called shuttle vectors, which can, because of an incorporated E. coli replicon, be multiplied in E. coli strains. Vectors of this type are disclosed, for example, in the European Patent Application with the publication No. (EP-A) 158,201.
It has now been found that pSG5 is temperature-sensitive.
The property of temperature-sensitivity for pSG5 is surprising because as yet no natural Streptomycetes plasmids having this property have been disclosed. Since pSG5 and the hybrid plasmids prepared with its replicon exhibit a wide host range, the new use of this plasmid according to the invention provides those skilled in the art with a large number of possibilities: When a plasmid which has the replicon of pSG5, containing a marker, is constructed and used to transform a compatible host strain, and then the temperature is raised above the threshold, the only transformants obtained after selection for the marker are those which have the plasmid integrated, in whole or in part, into the genome. Since such integrations essentially take place only in homologous regions of the genome, this method is suitable for finding such homologous regions in the genome of the host strain.
EP-A 0,243,856 discloses a method for the preparation of mutants, which comprises isolating from the starting strain the complete DNA, converting it into short fragments, integrating these into a plasmid which contains a marker, is temperature-sensitive and replicates in the starting strain, and transforming the resulting hybrid population into the starting strain, selecting the transformants by selection for the marker, eliminating the hybrid plasmids by increasing the temperature above the threshold of the temperature-sensitive plasmid, and selecting the mutants by renewed selection for the marker.
The term short fragments denotes DNA sections which are obtained with restriction enzymes which cut many times, such as Sau3A or Tad, but also with mechanical methods (ultrasound, shearing) and which contain neither the promoter region nor the translation stop signals.
Because the only cells surviving after elimination of the plasmids in a selection for the marker are those which have taken up the plasmid DNA into their chromosome (which preferably takes place via the homologous DNA integrated in the plasmid), the mutants are obtained directly.
The plasmid pSG5 is mentioned in EP-A 0,243,856 as a suitable starting plasmid. However, it is now possible according to the invention to dispense with mutation to give temperature-sensitive replication mutants when this plasmid is used. This means that not only are the mutation and the particularly elaborate selection dispensed with, but also the risk of generating undesired multiple mutations is avoided. The plasmid pSG5 is thus particularly well suited for this method.
The temperature-sensitivity of pSG5 is manifested in such a way that this plasmid becomes unstable and is no longer replicated at temperatures at or above 36°C. The upper limit of the utilizable temperature range depends on the host cell: it is, for example, 38°C in S. venezuelae, 39°C in S. lividans and 45°C with S. ghanaensis. When cultures which contain pSG5 or a derivative of this plasmid are incubated at a temperature of 36°C or above, the plasmid becomes diluted out and is no longer detectable after a few generations.
The use, according to the invention, of the pSG5 replicon can thus be utilized to find genes which are homologous to an existent gene. Thus a utilizable alternative to setting up a gene bank and screening with labeled DNA probes is available. This alternative is especially valuable when the result obtained from hybridization has not been conclusive. Another advantage of this method is that it is possible to avoid working with radioactive substances .
It is also possible correspondingly to find insertion elements (IS elements) and transposons which have been taken up into the genome of the host strain investigated: If, specifically, the plasmid which has been provided only with the marker and contains no other inserted DNA is used, then homologous regions are available only if an IS element or transposon has been transferred from the chromosome to the plasmid before raising the temperature. Hence selection for the marker makes it possible to find such DNA elements.
The said investigations can be carried out in accordance with the method for isolating mutants described in EP-A 0,243,856.
Thus the invention is associated with a number of advantages: 1. There already exists a family of vectors which is based on the pSG5 plasmid and, because of the wide host range, has a large variety of possible uses and which has various selection markers such as resistance to neomycin, thiostrepton, kanamycin (EP-A 0,158,201) and gentamicin (EP-A 0,24 8,2 07) as well as color markers such as melanin and other coloring substances or pigments (EP-A 0,257,416 and 0,257,417). 2. It is possible, by use of a plasmid which belongs to the said family of vectors and contains a marker which can be selected in E. coli, to extend the method disclosed in EP-A 0,243,856 to the use of cosmid banks and thus to the isolation of large DNA sections of about 40 kb: if the marker which can be selected in E. coli is integrated into the host chromosome, the genome of the mutants produced in this way can be transferred into a cosmid gene bank. Selection for the marker (expediently at the same time as the marker intrinsic to the cosmid) then immediately leads to the cosmid clone of interest. In this way the extremely elaborate screening by hybridization which was hitherto necessary is dispensed with. In contrast to the method disclosed in EP-A 0,243,856, it is thus possible to detect in one step large gene regions in the neighborhood of the mutated gene. Gene clusters can be isolated in this way, that is to say, for example, the ’genes for an entire biosynthetic pathway. Nor is there any longer a need for cleavage sites suitable for restriction enzymes to be present in the vicinity of the mutated gene.
The invention is explained in detail in the examples which follow. Unless indicated otherwise, percentage data herein relate to weight.
Example 1: Complete DNA isolation 0.1 g of mycelium from a 3-day old homogenized Streptomycetes culture of the strain S. ghanaensis (ATCC 14672; US Patent 3,674,866), which produced no melanin (mel') , is pelleted in a 1.5 ml Eppendorf reaction tube in an Eppendorf centrifuge for 1 min and then washed once with 0.5 ml of TE (10 mM tris-HCl, 1 mM EDTA (pH 8) containing 10% sucrose). The pellet is then resuspended in 0.5 ml of lysozyme solution (0.3 M sucrose, 25 mM tris-HCl (pH 8), 25 mM EDTA, 10 mg/ml lysozyme) and incubated at 37 °C for 60 min. 0.2 ml of 5% strength SDS solution is added and then the solution is thoroughly mixed and incubated at 65 °C for 10 min and subsequently cooled again to room temperature. Then 100 μΐ of phenol/chloroform (5 g of phenol, 5 ml of chloroform, 5 mg of 8-hydroxyquinoline, ml of 0.1 M tris (pH 8)) are added, and the suspension is mixed cautiously on a shaker (Vortex) until it is homogeneous. The mixture is then centrifuged in an Eppendorf centrifuge for 5 min, and the upper agueous phase is transferred into a new reaction tube. 70 μΐ of 3 M unbuffered sodium acetate and 700 μΐ of isopropanol are added to the DNA-containing solution. After mixing and incubation at room temperature for 15 minutes, the DNA is pelleted by centrifugation (5 min in an Eppendorf centrifuge) , and the supernatant is removed quantitatively. The DNA is resuspended in 300 μΐ of TE and then incubated with 10 μΐ of RNase solution (50 /xg of RNase/ml of H2O) at 37°C for 45 min. The RNase is inactivated by 100 μΐ of phenol/chloroform, and the denatured proteins are pelleted (5 min in an Eppendorf centrifuge) . The DNAcontaining solution is again treated with isopropanol (addition of 30 μΐ of 3 M sodium acetate and 400 μΐ of isopropanol, incubation at room temperature for 15 min). The DNA pellet obtained after centrifugation is washed twice with 70% strength ethanol and again pelleted. After the DNA has been dried it is taken up in 300 μΐ of TE and used for the further steps.
Example 2: Cleavage of the complete DNA with Sau3A μg of DNA is incubated in cleavage buffer (50 mM trisHCl (pH 8), 10 mM MgCl2, 50 mM NaCl) in the presence of 1 unit of Sau3A (manufactured by BRL-Gibco, Karlsruhe) at 37°C for 1 h. The reaction is stopped by phenol treatment, and the DNA is purified by ethanol precipitation.
Example 3: Cloning of fragments of complete DNA into the plasmid pGM4 pGM4 (EP-A 0,257,416 and 0,257,417) is completely linearized with BamHI in analogy to Example 2. The two DNA samples are mixed in cleavage buffer, heated to 70°C and adjusted to the ligase reaction conditions by addition of mercaptoethanol (final cone. 10 mM) and ATP (0.1 mM) . The mixture is incubated in the presence of 1 unit of T4 DNA ligase (Boehringer Mannheim) at 14°C for 12 h. The mixture is then transformed into protoplasts of the starting strain and plated out on regeneration plates. After about 20 h, a top layer of soft agar which contains sufficient thiostrepton for the final concentration in the plate to be 50 gg/ml is placed on the latter.
Example 4: Generation and selection of mutants The transformants are inclubated in S medium (Hopwood et al., Genetic Manipulation of Streptomyces, a Laboratory Manual, The John Innes Foundation, Norwich 1985) in a shake culture at 28°C for about 36 h. The temperature is then raised to 3 9°C and incubation is continued at this temperature for about 36 h. The culture is harvested sterile, washed in TE + 10% sucrose and incubated in complete medium containing thiostrepton (20 mg/1) at 39°C for a further 48 h. The mutants generated in this way are then plated out and characterized (incubation always at 39°C).
Example 5: Isolation of the mutated DNA The DNA is isolated as in Example 1 from the mutants, is cut with a restriction enzyme which has no cleavage sites in the integrated plasmid, and is religated with T4 DNA ligase. This results in the integrated plasmid, which now contains the mutated gene, being formed as the only cyclic DNA capable of replication. Retransformation into a suitable strain such as S. lividans is followed by selection for thiostrepton resistance and isolation of the plasmid which harbors the mutated gene from the transformants.
Claims (10)
1. The use of the pSG5 replicon for the preparation of temperature-sensitive hybrid plasmids.
2. A method for finding IS elements and transposons, which comprises providing a plasmid containing the pSG5 replicon with a marker, using the hybrid plasmid obtained in this way to transform Streptomycetes, incubating the transformants at a temperature above 36°C, selecting for the marker, and analyzing the DNA region via which the recombination has taken place.
3. A method for the preparation of Streptomycetes mutants, for the isolation of the mutated genes and for the isolation of the corresponding wild-type gene, which comprises isolating from the starting Streptomycetes strain the complete DNA, converting it into short fragments, integrating these into a hybrid plasmid which has the pSG5 replicon, containing a marker, and transforming the resulting hybrid plasmid population into the starting strain, selecting the transformants by selection for the marker, eliminating the hybrid plasmids by increasing the temperature above the threshold, and selecting the mutants by renewed selection for the marker.
4.The method as mutated genes mutants . claimed in claim 3, wherein the are isolated from the selected
5. The method as claimed in claim 4, wherein the corresponding wild-type genes are isolated using the mutated genes .
6. The method as claimed in claim 4, wherein the hybrid plasmid having the pSG5 replicon contains a marker which can be selected in E. coli, and wherein a cosmid bank is used in the isolation of the mutated genes.
7. Use according to claim 1, substantially as hereinbefore described.
8. A method according to claim 2, substantially as hereinbefore described and exemplified.
9. A method according to claim 3, substantially as hereinbefore described and exemplified.
10. A Streptomycetes mutant, a mutated gene or a corresponding wild-type gene, whenever obtained by a method claimed in any one of claims 3 to 6 or 9.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3809692A DE3809692A1 (en) | 1988-03-23 | 1988-03-23 | USE OF PSG5 AS A TEMPERATURE-SENSITIVE PLASMIDE |
Publications (2)
Publication Number | Publication Date |
---|---|
IE890898L IE890898L (en) | 1989-09-23 |
IE63496B1 true IE63496B1 (en) | 1995-05-03 |
Family
ID=6350421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE89889A IE63496B1 (en) | 1988-03-23 | 1989-03-22 | The use of pSG5 as a temperature-sensitive plasmid |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0334282B1 (en) |
JP (1) | JP2770975B2 (en) |
KR (1) | KR970003961B1 (en) |
AT (1) | ATE108485T1 (en) |
AU (1) | AU615524B2 (en) |
CA (1) | CA1335964C (en) |
DE (2) | DE3809692A1 (en) |
DK (1) | DK175475B1 (en) |
ES (1) | ES2056987T3 (en) |
FI (1) | FI95394C (en) |
HU (1) | HU213350B (en) |
IE (1) | IE63496B1 (en) |
IL (1) | IL89686A (en) |
NO (1) | NO178157C (en) |
PT (1) | PT90090B (en) |
ZA (1) | ZA892123B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3809691A1 (en) * | 1988-03-23 | 1989-10-12 | Hoechst Ag | METHOD FOR SELECTION OF LARGE DNA SECTIONS |
DE4011863A1 (en) * | 1990-04-12 | 1991-10-17 | Hoechst Ag | REGULATED GENE EXPRESSION IN STREPTOMYCETES |
FR2688515B1 (en) * | 1992-03-13 | 1995-03-31 | Institut Rech Agronomique | THERMOSENSITIVE PLASMID. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0158872B1 (en) * | 1984-03-31 | 1989-01-18 | Hoechst Aktiengesellschaft | Streptomycetes plasmid psg5, process for its preparation and its use |
DE3412093A1 (en) * | 1984-03-31 | 1985-10-10 | Hoechst Ag, 6230 Frankfurt | HYBRID PLASMIDE WITH A STREPTOMYCETE AND ESCHERICHIA COLI REPLICON |
DE3614310A1 (en) * | 1986-04-28 | 1987-10-29 | Hoechst Ag | METHOD FOR ISOLATING MUTED GENES AND THE CORRESPONDING WILD-TYPE GENES |
DE3627392A1 (en) * | 1986-08-13 | 1988-04-28 | Hoechst Ag | COLOR MARKER FOR CLONING IN STREPTOMYCES LIVIDANS |
-
1988
- 1988-03-23 DE DE3809692A patent/DE3809692A1/en not_active Withdrawn
-
1989
- 1989-03-21 AT AT89105012T patent/ATE108485T1/en not_active IP Right Cessation
- 1989-03-21 EP EP89105012A patent/EP0334282B1/en not_active Expired - Lifetime
- 1989-03-21 FI FI891335A patent/FI95394C/en not_active IP Right Cessation
- 1989-03-21 ES ES89105012T patent/ES2056987T3/en not_active Expired - Lifetime
- 1989-03-21 IL IL8968689A patent/IL89686A/en not_active IP Right Cessation
- 1989-03-21 ZA ZA892123A patent/ZA892123B/en unknown
- 1989-03-21 DE DE58908022T patent/DE58908022D1/en not_active Expired - Lifetime
- 1989-03-22 HU HU891388A patent/HU213350B/en unknown
- 1989-03-22 IE IE89889A patent/IE63496B1/en not_active IP Right Cessation
- 1989-03-22 JP JP1067773A patent/JP2770975B2/en not_active Expired - Lifetime
- 1989-03-22 AU AU31582/89A patent/AU615524B2/en not_active Expired
- 1989-03-22 KR KR1019890003551A patent/KR970003961B1/en not_active IP Right Cessation
- 1989-03-22 DK DK198901460A patent/DK175475B1/en not_active IP Right Cessation
- 1989-03-22 NO NO891267A patent/NO178157C/en not_active IP Right Cessation
- 1989-03-22 CA CA000594516A patent/CA1335964C/en not_active Expired - Lifetime
- 1989-03-22 PT PT90090A patent/PT90090B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE58908022D1 (en) | 1994-08-18 |
DE3809692A1 (en) | 1989-10-12 |
NO891267D0 (en) | 1989-03-22 |
KR970003961B1 (en) | 1997-03-24 |
IL89686A0 (en) | 1989-09-28 |
CA1335964C (en) | 1995-06-20 |
NO178157B (en) | 1995-10-23 |
PT90090A (en) | 1989-11-10 |
FI95394C (en) | 1996-01-25 |
ATE108485T1 (en) | 1994-07-15 |
NO891267L (en) | 1989-09-25 |
FI95394B (en) | 1995-10-13 |
KR890014741A (en) | 1989-10-25 |
ZA892123B (en) | 1989-11-29 |
HU213350B (en) | 1997-05-28 |
NO178157C (en) | 1996-01-31 |
AU3158289A (en) | 1989-09-28 |
JP2770975B2 (en) | 1998-07-02 |
AU615524B2 (en) | 1991-10-03 |
DK146089A (en) | 1989-09-24 |
JPH029376A (en) | 1990-01-12 |
EP0334282A2 (en) | 1989-09-27 |
PT90090B (en) | 1994-06-30 |
DK146089D0 (en) | 1989-03-22 |
FI891335A0 (en) | 1989-03-21 |
HUT50511A (en) | 1990-02-28 |
FI891335A (en) | 1989-09-24 |
DK175475B1 (en) | 2004-11-08 |
EP0334282B1 (en) | 1994-07-13 |
EP0334282A3 (en) | 1989-11-29 |
ES2056987T3 (en) | 1994-10-16 |
IL89686A (en) | 1994-12-29 |
IE890898L (en) | 1989-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4952500A (en) | Cloning systems for Rhodococcus and related bacteria | |
JPH0239889A (en) | Macloride biosynthetic gene for use in streptomyces and other organisms | |
Chung | Tn4556, a 6.8-kilobase-pair transposable element of Streptomyces fradiae | |
JP3289726B2 (en) | Clavalanic acid biosynthesis gene | |
EP0783584A1 (en) | Vectors and process for producing high purity 6,12-dideoxyerythromycin a by fermentation | |
CA1335964C (en) | Use of psg5 as a temperature-sensitive plasmid | |
EP0213898B1 (en) | A host-vector system | |
US5198360A (en) | Dna sequence conferring a plaque inhibition phenotype | |
Santos et al. | Insertional mutagenesis in the vitamin B 2 producer fungus Ashbya gossypii | |
EP0243856B1 (en) | Process for the isolation of mutants, mutant genes and corresponding wild-type genes | |
US4992371A (en) | Hybrid plasmids having a streptomycetes replicon and an escherichia coli replicon | |
DK167775B1 (en) | PLASMID PSG5, METHOD OF INSULATION THEREOF, ITS APPLICATION FOR THE CONSTRUCTION OF PLASMID VECTORS, HYBRID PLASMIDES CONTAINING PSG5 OR ITS INTACT REPLICATION REGION, AND THE STREPTOMYCS GHANA 32 | |
NZ228441A (en) | Psg5 plasmid used in isolating is elements, transposons and mutated genes | |
US5776735A (en) | Process for dienone macrolides | |
EP0067564A2 (en) | Composite plasmids | |
AU610411B2 (en) | Isolation and characterisation of genes resistant to anthracycline antibiotics | |
EP0618297A1 (en) | Novel bacterial plasmid shuttle vectors for streptomycetes and escherichia coli |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK9A | Patent expired |